Kinaxis Inc. (TSE:KXS – Get Free Report) Senior Officer Christopher John Blaine Fitzgerald sold 2,177 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of C$156.26, for a total transaction of C$340,172.58.
Kinaxis Stock Performance
Shares of Kinaxis stock opened at C$159.52 on Monday. The firm’s fifty day simple moving average is C$166.09 and its 200-day simple moving average is C$165.37. The stock has a market capitalization of C$3.21 billion, a price-to-earnings ratio of 158.32, a PEG ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a 12 month low of C$132.93 and a 12 month high of C$190.17. The company has a debt-to-equity ratio of 12.12, a current ratio of 1.89 and a quick ratio of 2.29.
Wall Street Analyst Weigh In
Separately, CIBC cut their price objective on shares of Kinaxis from C$175.00 to C$170.00 in a report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of C$192.00.
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Featured Stories
- Five stocks we like better than Kinaxis
- Investing in Travel Stocks Benefits
- How to Build the Ultimate Everything ETF Portfolio
- What is the S&P 500 and How It is Distinct from Other Indexes
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.